Clinical Trial Update: Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Non Erosive Reflux Disease [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 study evaluating the safety and efficacy of CJ-12420 in patients with non-erosive reflux disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-erosive Reflux Disease

Drugs mentioned

• CJ-12420

Snippet

Sponsor: HK inno.N Corporation | Conditions: Non-erosive Reflux Disease | Phase 3 | Status: COMPLETED